Preparing for OBBBA Impacts: Medicare DSH and 340B Updates
About this episode
This episode discusses the impacts of the One Big Beautiful Bill Act on Medicare DSH and the 340B drug pricing program.
This episode covers the impact of the One Big Beautiful Bill Act (OBBBA) on Medicare DSH and the 340B drug pricing program. PYA presenters explain how new Medicaid eligibility requirements may affect hospital reimbursement, patient mix, and program eligibility, and outline strategies for accurately capturing Medicaid eligible days. The discussion also reviews recent 340B developments, including legal rulings, the status of the rebate model, CMS drug pricing surveys, and growing state-level legislative activity. Hospitals will gain a clearer understanding of current risks, operational considerations, and areas requiring proactive monitoring.
More episodes of PYA Webinar Recast
- TEAM Ready: Turning Claims Data into Financial Performance
- Top 10 Healthcare Compliance Risk Areas Managers Need to Know
- How to Mitigate Risk While Auditing for Revenue Integrity: Sample Design, Interpreting Results, & Navigating Compliance Next Steps
- Happy New Year: New Proposed Rules, New Payment Models, New Guidance
- Let's Get Rural: Key Policy, Payment, & Program Changes Shaping Rural Care in 2026
- 2026 MPFS Final Rule Part 2: Telehealth, Global Payments, and Skin Substitutes
Explore listener stats, chart rankings, contacts and more on the PYA Webinar Recast podcast page.